Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Medexus Pharmaceuticals had annual revenue of $99.33M USD, down -8.31%. Medexus Pharmaceuticals had revenue of $24.65M in the quarter ending March 31, 2026, a decrease of -0.41%.

• Revenue: $99.33M
• Revenue Growth: -8.31%
• P/S Ratio: 1.16
• Revenue / Employee: $1.09M
• Employees: 91
• Market Cap: 161.47M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	99.33M	-9.00M	-8.31%
Mar 31, 2025	108.33M	-4.72M	-4.18%
Mar 31, 2024	113.05M	4.96M	4.59%
Mar 31, 2023	108.10M	31.40M	40.93%
Mar 31, 2022	76.70M	-2.96M	-3.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error